Pernod Ricard (RI) AGM 2025 summary
Event summary combining transcript, slides, and related documents.
AGM 2025 summary
27 Dec, 2025Opening remarks and agenda
The assembly was convened in compliance with legal requirements, with a provisional quorum of 80.92% and final quorum of 81.23% representing over 204 million shares.
Chairman & CEO Alexandre Ricard opened the meeting, with attendance from the Board, Lead Independent Director, EVP Finance & Tech, and Statutory Auditor Deloitte & Associés.
The agenda included the management report, financial performance, board updates, shareholder proposals, and voting on 25 resolutions.
Financial performance review
Net sales reached EUR 10,959 million, down 3% organically and 5.5% reported, mainly due to decreases in China, the US, and global travel retail.
Organic operational margin increased by 64 basis points; group share of net profit rose 10% to EUR 1,626 million.
Free cash flow grew 18% to EUR 1,133 million; net debt reduced to EUR 10,727 million.
The group maintained or gained market share in 12 of 17 main markets, with strong performances in India, Japan, Nigeria, Turkey, and South Africa.
Portfolio management included disposals of non-core assets and focus on premiumisation.
Board and executive committee updates
Two new independent directors, Albert Baladi and Jean Lemierre, were appointed; Namita Shah stepped down.
The board consists of 14 members, with balanced gender and nationality representation, and a 97% attendance rate.
Board comprised of independent, employee, and non-French directors, with diverse skills in management, finance, governance, and innovation.
Five dedicated committees (Audit, Nominations & Governance, Compensation, Strategic, CSR) supported Board activities.
Lead Independent Director engaged with top investors and led Board reviews.
Latest events from Pernod Ricard
- Sales and profit fell, but free cash flow improved and medium-term growth targets reaffirmed.RI
H1 202619 Feb 2026 - Q1 organic sales fell 7.6%, but H2 is expected to improve as key markets recover.RI
Q1 20263 Feb 2026 - Organic sales down 1%, margins up, net profit down 35%, FY25 growth expected.RI
H2 202423 Jan 2026 - Q1 sales declined 5.9% organically, with China and US driving the downturn; guidance unchanged.RI
Q1 202519 Jan 2026 - Stable sales, margin gains, and a €4.70 dividend headline a governance-focused AGM.RI
AGM 202415 Jan 2026 - Margin and cash flow improved despite sales and profit declines amid FX and China headwinds.RI
H1 20259 Jan 2026 - Q3 FY25 organic net sales fell 3%, but FY25 outlook and €2.35 dividend were confirmed.RI
Q3 202521 Dec 2025 - Organic sales fell 3% but margin and cash flow improved; FY26 to be a transition year.RI
H2 202523 Nov 2025 - Sharpened pricing, focused portfolio, and stronger wholesaler ties drive renewed brand momentum.RI
Investor Update18 Nov 2025